Trial intelligence / Profile preview

Elimination kinetics of hydrogen cyanide after inhalation and hydroxocobalamin antidote

2011-000206-22Phase 4Completed

Sponsor: University of Helsinki, Department of Chemistry
Start: Mar 2011
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries: 1

Overview

Phase 4, open-label, single-arm trial of hydroxocobalamin in cyanide poisoning, sponsored by University of Helsinki, Department of Chemistry. Primary endpoint: Effect of hydroxocobalamin on HCN elimination kinetics. Started Mar 2011; status: completed.

Drugs

hydroxocobalamin

Conditions

cyanide poisoning

Beyond the preview

Go deeper on 2011-000206-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000206-22.